ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,455Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 586

$570K Total Retail Price of All Prescriptions

Rank: 12 out of 586

253 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 253 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 253 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 5,267 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 581 219 1 1
OMEPRAZOLE 447 222 2 3
LEVOTHYROXINE SODIUM 391 239 3 2
CITALOPRAM HBR 378 230 4 12
TRAZODONE HCL 362 179 5 20
RISPERIDONE 306 30 6 46
LISINOPRIL 288 207 7 4
FUROSEMIDE 248 205 8 9
SERTRALINE HCL 247 45 9 21
QUETIAPINE FUMARATE 233 157 10 50
HYDROCHLOROTHIAZIDE 207 94 11 10
CYMBALTA 198 93 12 29
WARFARIN SODIUM 181 175 13 13
OLANZAPINE 165 42 14 73
METFORMIN HCL 156 93 15 6
HYDROCODONE-ACETAMINOPHEN 152 120 S3 16 5
AMLODIPINE BESYLATE 141 113 17 7
GABAPENTIN 137 106 18 11
ALENDRONATE SODIUM 126 71 19 23
FLUOXETINE HCL 115 35 20 24
DIVALPROEX SODIUM 112 22 21 69
ABILIFY 105 0 22 116
METOPROLOL TARTRATE 102 58 23 26
LANTUS 100 44 24 33
DONEPEZIL HCL 100 92 24 40
BUSPIRONE HCL 99 26 26 151
OXYBUTYNIN CHLORIDE 98 42 27 83
NYSTOP 90 70 28 171
ATENOLOL 90 59 28 34
POLYETHYLENE GLYCOL 3350 90 34 28 47
BENZTROPINE MESYLATE 86 13 R 31 112
ZIPRASIDONE HCL 84 0 32 131
SEROQUEL 81 52 33 118
POTASSIUM CHLORIDE 81 68 33 14
MORPHINE SULFATE ER 78 78 S2 35 49
DIVALPROEX SODIUM ER 72 0 36 117
NAMENDA 72 72 36 54
FLUTICASONE PROPIONATE 70 18 38 28
TAMSULOSIN HCL 69 64 39 27
IBUPROFEN 65 19 40 43
KLOR-CON M20 61 25 41 92
HALOPERIDOL 59 45 42 174
GLYBURIDE 59 0 R 42 101
CARVEDILOL 57 53 44 30
PROPRANOLOL HCL 54 18 45 115
OXYBUTYNIN CHLORIDE ER 53 25 46 108
MIRTAZAPINE 53 28 46 64
KLOR-CON 10 52 15 48 160
LAMOTRIGINE 51 13 49 67
CLOPIDOGREL 50 32 50 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.